Apple Inc. AAPL has posted a terrific fiscal Q1 2020 quarter a half hour after Tuesday afternoon's closing bell, with $4.99 per share beating bottom line estimates of $4.54, on revenues of $91.8 billion, easily outpacing the $87.7 billion in the Zacks consensus, and up 9% year over year. Apple has not missed on earnings in nearly four full years.
iPhone sales, in particular, surprised to the upside, bringing in $56 billion from $51.2 billion estimated, up 8% year over year. Wearables also surprised to the upside to $10 billion from the $9.7 billion expected, while Services revenue came in a tad light to $12.7 billion. Gross Margins improved over consensus by 30 basis points to 38.4%. and the company has now stockpiled $207 billion in cash.
Even better, revenue guidance for fiscal Q2 has been bumped up to a range of $63-67 billion, a marked improvement from our expected $62.5 billion. And even though the stock had doubled in the last year to all-time highs, shares continue to climb in the after-market, +2.7% immediately following the earnings release.
Zacks Rank #2 (Buy)-rated Starbucks SBUX reported fiscal Q1 2020 earnings after Tuesday's market close, beating on the bottom line by 3 cents to 79 cents per share, on quarterly sales of $7.1 billion which were in-line with the Zacks consensus. The company now counts 18.9 million active members in its reward program. Shares are down a tad on the news, though the company did maintain full-year 2020 guidance.
With Starbucks, however, the story is always in same-store sales, or "comps": Global Comps rose 5% year over year, while in the U.S. they grew 6%. Both figures were above consensus. China comps grew 3%, with 10.2 million customers in China rising 40% year over year. Of course, the recent coronavirus issue is not reflected in these quarterly numbers, so we will see if guidance keeps pace the longer the crisis continues.
Advanced Micro Devices AMD has beaten expectations on its Q4 bottom line by 2 cents to 32 cents per share, on $2.13 billion in revenues which were above the Zacks consensus $2.10 billion and up 50% year over year. This was led by its Computing & Graphics division, which currently accounts for 70% of AMD's sales. However, Q1 revenue guidance was lower than anticipated -- $1.80 billion versus $1.84 originally estimated -- which has helped send shares down 2.5% in late trading Tuesday.
eBay EBAY was also able to surpass expectations on both top and bottom lines, also after Tuesday's closing bell: 81 cents per share improved on the 75 cents analysts were looking for, and 71 cents reported in the year-ago quarter. Sales were slightly to the positive as well: $2.82 billion versus $2.81 billion in the Zacks consensus, but still down 2% from a year ago. Q4 Gross Merchandise Guidance fell to $23.3 billion from $23.7 billion.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Click to get this free report eBay Inc. (EBAY) : Free Stock Analysis Report Apple Inc. (AAPL) : Free Stock Analysis Report Advanced Micro Devices, Inc. (AMD) : Free Stock Analysis Report Starbucks Corporation (SBUX) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research